Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Normosang 25 mg/ml, concentrate for solution for infusion

Active Ingredient:
human hemin
Company:  
Recordati Rare Diseases UK Ltd See contact details
ATC code: 
B06AB
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Information for Healthcare Professionals administering Normosang

{healthcare_pro_orange} For Healthcare Professionals
This guide is intended for Health Care Professionals to highlight the risks associated with NORMOSANG® 25 mg/ml, concentrate for solution for infusion administration (thrombosis, extravasation and necrosis) and the precautions to take in order to avoid them.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Recordati Rare Diseases UK Ltd
Company image
Address
Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, UK
Telephone
+44 (0)1491 414 333
Fax
+ 44(0)1491 414 443
Medical Information e-mail
[email protected]
WWW
www.recordatirarediseases.uk
Stock Availability
+44 (0) 1491 414 333
Stock Availability
[email protected]
Medical Information Direct Line
+44 (0)330 500 1155